Lung function and bronchial hyper-responsiveness 11 years after hospitalization for bronchiolitis

M K Hyvärinen1, A Kotaniemi-Syrjänen, T M Reijonen

  • 1Department of Paediatrics, Kuopio University and Kuopio University Hospital, Kuopio, Finland. ylinen@hytti.uku.fi

Insights

Infants hospitalized for respiratory syncytial virus (RSV) bronchiolitis may experience reduced lung function. Early atopy and maternal smoking are linked to later bronchial hyper-responsiveness (BHR) in children.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Epidemiology

Background:

  • Infants hospitalized for wheezing, particularly those with atopy and not caused by respiratory syncytial virus (RSV), face a higher risk of developing asthma later in life.
  • Bronchiolitis in infancy is a significant risk factor for subsequent respiratory issues, including asthma and abnormal lung function.

Purpose of the Study:

  • To evaluate early risk factors for abnormal lung function and bronchial hyper-responsiveness (BHR) in children previously hospitalized for bronchiolitis during infancy.
  • To identify specific early indicators that predict long-term respiratory health outcomes in this vulnerable population.

Main Methods:

  • Longitudinal study of 81 children hospitalized for bronchiolitis before age two.
  • Assessment of lung function using flow-volume spirometry (FVS) and BHR via methacholine and exercise challenge tests at a median age of 12.3 years.
  • Retrospective analysis of early data including childhood atopy, viral etiology of bronchiolitis, and maternal smoking during pregnancy.

Main Results:

  • Respiratory syncytial virus (RSV) bronchiolitis was associated with a restrictive lung function pattern (reduced forced vital capacity).
  • Early sensitization to inhalant allergens and maternal smoking during pregnancy were significantly associated with exercise-induced BHR.
  • Early atopic dermatitis was linked to methacholine-induced BHR.

Conclusions:

  • RSV bronchiolitis in infancy is linked to persistent restrictive lung function abnormalities.
  • Early signs of atopy and exposure to maternal smoking during pregnancy are identified as potential contributors to the development and persistence of bronchial hyper-responsiveness (BHR).
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...